Svein Arild Mathisen
Director/Board Member presso SPRINT BIOSCIENCE AB
Profilo
Svein Arild Mathisen has held various director positions in multiple biotechnology companies, including iCell Science AB, Athera Biotechnologies AB, Betagenon Sweden AB, Arild Capital AB, Genagon Therapeutics AB, Balticgruppen Bio AB, and Betagenon Bio AB.
He is currently serving as the Chairman of iCell Science AB and Director of the other mentioned companies.
In addition, he is also a Director at Sprint Bioscience AB since 2020.
Prior to his current roles, Mathisen was the President, Chief Executive Officer, and Director of BioInvent International AB from 2012 to 2013.
He has also served as Chairman of ArcticZymes Technologies ASA and Gabather AB.
Furthermore, Mathisen was an Independent Director at Camurus AB from 2010 to 2018 and a Director at SwedenBIO Service AB.
He holds a graduate degree from the Norwegian University of Science & Technology.
Posizioni attive di Svein Arild Mathisen
| Società | Posizione | Inizio |
|---|---|---|
| SPRINT BIOSCIENCE AB | Director/Board Member | 01/01/2020 |
| iCell Science AB | Chairman | - |
Athera Biotechnologies AB
 Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
| Arild Capital AB | Director/Board Member | - |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Director/Board Member | - |
Balticgruppen Bio AB
 Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation. | Director/Board Member | - |
Betagenon Sweden AB
 Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Director/Board Member | - |
| Betagenon Bio AB | Director/Board Member | - |
Precedenti posizioni note di Svein Arild Mathisen
| Società | Posizione | Fine |
|---|---|---|
| CAMURUS AB | Director/Board Member | 03/05/2018 |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ | ░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░ | - |
Formazione di Svein Arild Mathisen
| Norwegian University of Science & Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 5 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| ARCTICZYMES TECHNOLOGIES ASA | Health Technology |
| CAMURUS AB | Health Technology |
| SPRINT BIOSCIENCE AB | Health Technology |
| GABATHER AB | Health Technology |
| Aziende private | 8 |
|---|---|
Athera Biotechnologies AB
Athera Biotechnologies AB Pharmaceuticals: MajorHealth Technology Athera Biotechnologies AB operates as a biopharmaceutical company which focuses on developing targeted anti-inflammatory biological candidate drugs and companion diagnostics. It has a proprietary program the fully human antibody PC-mAb. The frim develops a biomarker and companion diagnostic CVDefine® kit. Its PC-mAb is a fully human monoclonal antibody which neutralizes a key driver of vascular inflammation, phosphorylcholine, which targets market of reducing secondary cardiovascular events, focusing on high-risk patients with low anti-PC levels. The company was founded by Johan Frostegard in 2002 and is headquartered in Stockholm, Sweden. | Health Technology |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Commercial Services |
Betagenon Sweden AB
Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Health Technology |
| iCell Science AB | |
| Arild Capital AB | |
Genagon Therapeutics AB
Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
Balticgruppen Bio AB
Balticgruppen Bio AB Pharmaceuticals: MajorHealth Technology Balticgruppen Bio AB is a Swedish biopharmaceutical company that develops activated protein kinase. The company was founded by Olof Karlsson, Thomas Edlund, and Helena Edlund. Thomas Edlund has been the CEO since incorporation. | Health Technology |
| Betagenon Bio AB |
- Borsa valori
- Insiders
- Svein Arild Mathisen
